MedTrace Logo

Clinical Characteristics and In-hospital Death of a Chilean COVID-19 Prospective Cohort

NCT04758039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 395

Last updated 2021-02-18

No results posted yet for this study

Summary

The investigators planned to examine a cohort of admitted patients at University of Chile Clinical Hospital with COVID-19 diagnosis. Authors report data on mortality, ICU admission, need of invasive mechanical ventilation, awake and ventilated prone positioning, use of High Flow Nasal Cannula, Thromboembolic disease, Acute Kidney Injury (AKI) and Renal Replacement Therapy. Additionally, the risk of in-hospital death according to chronic disease burden and severity of illness at admission was assessed.

Conditions

  • Corona Virus Infection

Sponsors & Collaborators

  • University of Chile

    lead OTHER

Principal Investigators

  • Francisco J Gonzalez, MD · University of Chile

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-13
Primary Completion
2020-07-10
Completion
2020-07-10

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04758039 on ClinicalTrials.gov